Peptides for Erectile Dysfunction

Erectile Dysfunction Peptide Therapy Overview

PT-141 (Bremelanotide) is unique among ED treatments because it works through melanocortin receptors in the brain rather than the vascular system. This makes it effective for men who don't respond to PDE5 inhibitors like Viagra or Cialis. While FDA-approved for female sexual dysfunction (HSDD), it is widely used off-label for male ED.

• Works through nervous system, not blood vessels
• Effective for PDE5 inhibitor non-responders
• Enhances desire alongside physical arousal
• No interaction with nitrates or blood pressure meds
• Available as injection or nasal spray

How Erectile Dysfunction Peptides Work

PT-141 activates melanocortin-4 receptors (MC4R) in the hypothalamus, which is the brain region responsible for sexual arousal signaling. Unlike PDE5 inhibitors (Viagra, Cialis) that increase blood flow by relaxing blood vessels, PT-141 works upstream — it enhances the neurological "desire" signal that initiates arousal. This means it can work even when vascular ED treatments fail, such as in men with severe diabetes, post-prostatectomy nerve damage, or those on nitrate medications. The effect typically begins 45 minutes after injection and can last 24–72 hours. Kisspeptin-10 is an emerging option that works through the hypothalamic-pituitary-gonadal axis to stimulate natural testosterone and gonadotropin release, addressing ED caused by hormonal imbalance.

Peptides Used for Erectile Dysfunction

Who Is Erectile Dysfunction Peptide Therapy For?

PT-141 is most appropriate for men who have tried PDE5 inhibitors (Viagra, Cialis) without adequate results, men who cannot take PDE5 inhibitors due to nitrate medications or blood pressure issues, and men whose ED has a significant psychological or desire-based component. It's also used by men with neurological ED causes (spinal cord injury, post-surgical). Kisspeptin-10 may be better suited for men with documented hormonal imbalances contributing to ED.

PT-141 is typically prescribed at 1.75mg subcutaneously, self-administered 45–60 minutes before anticipated sexual activity. Most providers limit use to 2–3 times per week to prevent receptor desensitization. Common side effects include transient nausea (manageable with anti-emetics or lower starting doses of 1mg), flushing, and mild headache. Nasal spray formulations are also available from compounding pharmacies. Labs should include testosterone (total and free), prolactin, and metabolic panel before starting therapy.

Erectile Dysfunction Peptide News

News aggregated via Google News. Inclusion does not imply endorsement.

Erectile Dysfunction Guides & Resources

Erectile Dysfunction Peptide FAQs